Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir

Daclatasvir (DCV) and asunaprevir (ASV) are direct-acting antivirals (DAAs) used in the treatment of chronic hepatitis C virus (HCV) infection. Combined therapy with DCV and ASV shows high efficacy and safety even in patients with cirrhosis. We encountered a patient exhibiting severe hyperbilirubine...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Gastroenterol
Asıl Yazarlar: Baba, Hayato, Tajiri, Kazuto, Nagata, Kohei, Kawai, Kengo, Minemura, Masami, Sugiyama, Toshiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2016
Konular:
Single Case
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965544/
https://ncbi.nlm.nih.gov/pubmed/27504082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000447486
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller